LGVN - Longeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10 2023 | Benzinga
MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today that it will report its third quarter 2023 financial results prior to the market open on Friday November 10, 2023. The Company will host a conference call and webcast that day to discuss the results, and provide an update on its clinical programs and corporate activities. A question-and-answer session will follow the prepared remarks.
| Title |
| Longeveron Third Quarter 2023 Financial Results |
| Date |
| Friday, November 10, 2023 |
| Time |
| 8:00 AM Eastern Time |
| Conference Call Details |
| 1-877-407-0789 - Investors Dial 1-201-689-8562- ... |